medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number S2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2006; 44 (S2)

Histocompatibility in the Cadaveric Donor Program for kidney transplantation

Arrazola GA, Martínez ÁJC
Full text How to cite this article

Language: Spanish
References: 8
Page: 19-24
PDF size: 88.52 Kb.


Key words:

major histocompatibility complex, human leukocyte antigen, allograft.

ABSTRACT

The incidence and prevalence of end-stage renal disease (ESRD) have increased each year throughout the world. The development of ESRD is associated with a substantial reduction in health-related quality of life and premature death. Kidney transplantation is the treatment of choice for ESRD, as it extends survival, improves quality of life and is less costly than dialysis. The half-life of cadaveric kidney survival after the first year varies in a statistically significant way with the number of incompatibilities for the six antigens of HLA-A, -B and -DR loci. Cadaveric donors completely matched for the 3 loci (six antigens) with recipients having their first transplant were shown to have 10-year survivals of 65 %. We have a data base of HLA frequencies HLA-A,-B,-DR (HLA class I and class II) so we can provide the physicians with this important information, so they can find the best matched recipient. The results of frequencies are similar to those reported from other groups in our country.


REFERENCES

  1. Rodey GE. HLA beyond Tears. Second edition. Durango, CO, USA: De Novo; 2000.

  2. Norman DJ. Primer on Transplantation. Second edition. New Jersey, USA: American Society of Transplantation National Office; 2001.

  3. Danovitch GM. Handbook of kidney transplantation. Fourth edition. Philadelphia, PA, USA: Lippincott Williams and Wilkins; 2005.

  4. Torres MJ, Rodríguez-Pérez JC. Los nuevos conocimientos sobre las moléculas HLA de clase II y una mejor asignación de los órganos para trasplante. Nefrología 2002; 22 (1): 4-8.

  5. Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D et al. Consensus Guidelines on eligibility for Kidney Transplantation. CMAJ 2005; 173 (10): 1-25.

  6. American Society for Histocompatibility and Immunogenetics. ASHI Laboratory Manual. Fourth edition. Vol II. USA: ASHI; 2000.

  7. Arellano J, Vallejo M, Gomez-Estrada H, Kretschmer R. HLA profile of the Mexican Mestizo population. Tissue Antigens 1981; 18: 242-246.

  8. Gorodezky C, Terán L, Escobar-Gutiérrez A. HLA frequencies in a Mexican mestizo population. Tissue Antigens 1979; 14: 347-352.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2006;44